GlaxoSmithKline gets green light to sell Advair as COPD drug

11/19/2003 | Wired magazine

GlaxoSmithKline's biggest seller, Advair, has been approved for treating patients with chronic obstructive pulmonary disease, or COPD. Already used to treat asthma, the FDA said the drug can now be used as a maintenance treatment for COPD patients with chronic bronchitis.

View Full Article in:

Wired magazine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA